FLUCLOXACILLIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 11 adverse event reports in the FDA FAERS database where FLUCLOXACILLIN was used for Psoriasis.
Most Reported Side Effects for FLUCLOXACILLIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Metabolic acidosis | 211 | 14.1% | 35 | 119 |
| Drug ineffective | 136 | 9.1% | 33 | 79 |
| Drug interaction | 134 | 9.0% | 22 | 56 |
| Acute kidney injury | 112 | 7.5% | 22 | 76 |
| Pyroglutamic acidosis | 83 | 5.6% | 11 | 59 |
| Pyrexia | 71 | 4.8% | 8 | 54 |
| Nausea | 61 | 4.1% | 1 | 40 |
| Diarrhoea | 58 | 3.9% | 8 | 37 |
| Drug reaction with eosinophilia and systemic symptoms | 57 | 3.8% | 8 | 25 |
| Off label use | 56 | 3.7% | 26 | 27 |
| Rash | 51 | 3.4% | 4 | 21 |
| Vomiting | 51 | 3.4% | 1 | 44 |
| Renal failure | 50 | 3.3% | 23 | 26 |
| Jaundice | 49 | 3.3% | 0 | 39 |
| Liver function test abnormal | 48 | 3.2% | 4 | 41 |
Other Indications for FLUCLOXACILLIN
Product used for unknown indication (346)
Cellulitis (123)
Staphylococcal infection (98)
Staphylococcal bacteraemia (79)
Wound infection (40)
Antibiotic therapy (38)
Infection (36)
Device related infection (25)
Arthritis bacterial (23)
Osteomyelitis (22)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)